Is a complete CYTK research report available?

No complete published report is available for Cytokinetics, Incorporated (CYTK) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Cytokinetics, Incorporated (CYTK)

NASDAQ: CYTK · USD

$61.3

-0.21 (-0.3%)· Recorded snapshot

Market cap	8.5B
Revenue (ttm)	67.7M
Net income (ttm)	-894M
EPS (ttm)	-$7.18
Shares out	139M
Volume	1,004,194
Beta	0.41

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 67.7M
Net income (ttm): -894M
EPS (ttm): -$7.18
Market cap: 8.5B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	持有

Metric	Value
Amount currency	USD
CIK code	0001061983
Company name	Cytokinetics, Incorporated
Country	United States
Country code	US
CUSIP number	23282W605
Earnings date	2026-11-04
Earnings time	amc
Employees	673
Employees change	175
Employees growth	35.14%
Enterprise value	$8.8B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1997
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2004-04-29
Is primary listing	Yes
Is SPAC	No
ISIN number	US23282W6057
Last 10-K release date	2026-02-26
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2013-06-25
Last stock split type	Reverse
Market cap	$8.5B
Market cap category	Mid-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$61.31
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	CYTK
U.S. state	California
Website	https://www.cytokinetics.com

Metric

Value

Amount currency

USD

CIK code

0001061983

Company name

Cytokinetics, Incorporated

Country

United States

Country code

CUSIP number

23282W605

Earnings date

2026-11-04

Earnings time

amc

Employees

673

Employees change

175

Employees growth

35.14%

Enterprise value

$8.8B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1997

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2004-04-29

Is primary listing

Yes

Is SPAC

ISIN number

US23282W6057

Last 10-K release date

2026-02-26

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split date

2013-06-25

Last stock split type

Reverse

Market cap

$8.5B

Market cap category

Mid-Cap

Next earnings date

2026-11-04

Options

Yes

Price

$61.31

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

CYTK

U.S. state

California

Website

https://www.cytokinetics.com

Metric	Value
Earnings yield	-11.72%
EV/Sales	128.01x
FCF / EV yield	-6.7%
FCF yield	-6.91%
Forward EV/Sales	33.09x
Forward P/S	32.1x
P/S ratio	124.19x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Earnings yield

-11.72%

EV/Sales

128.01x

FCF / EV yield

-6.7%

FCF yield

-6.91%

Forward EV/Sales

33.09x

Forward P/S

32.1x

P/S ratio

124.19x

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
Operating margin	-1,046.12%
Pretax margin	-1,321.12%
Profit per employee	$-1.3M
Revenue per employee	$100,550
ROA	-28.09%
ROA (5Y)	-25.94%
ROCE	-40.61%
ROIC	-46.78%
SBC / revenue	188.13%

Metric

Value

Operating margin

-1,046.12%

Pretax margin

-1,321.12%

Profit per employee

$-1.3M

Revenue per employee

$100,550

ROA

-28.09%

ROA (5Y)

-25.94%

ROCE

-40.61%

ROIC

-46.78%

SBC / revenue

188.13%

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth	-21.07%
Revenue growth (Q)	-57.13%
Revenue growth (QoQ)	47.89%
Revenue growth 10Y	7.8%
Revenue growth 3Y	89.45%
Revenue growth 5Y	3.2%
Revenue growth years	2

Metric

Value

EPS growth years

Net income growth years

Revenue growth

-21.07%

Revenue growth (Q)

-57.13%

Revenue growth (QoQ)

47.89%

Revenue growth 10Y

7.8%

Revenue growth 3Y

89.45%

Revenue growth 5Y

3.2%

Revenue growth years

Metric	Value
Capital expenditures	$-25.3M
Depreciation and amortization	$12.5M
EBIT	$-707.9M
EBITDA	$-695.4M
EPS	$-7.18
FCF per share	$-4.18
Financing cash flow	$1.2B
Free cash flow	$-580.7M
Free cash flow minus SBC	$-708M
Gross profit	$-337.4M
Investing cash flow	$-503.7M
Net borrowing	$315M
Net cash flow	$181.8M
Net income	$-894M
Operating cash flow minus SBC	$-682.8M
Operating income	$-707.9M
Revenue	$67.7M
Stock-based compensation	$127.3M

Metric

Value

Capital expenditures

$-25.3M

Depreciation and amortization

$12.5M

EBIT

$-707.9M

EBITDA

$-695.4M

EPS

$-7.18

FCF per share

$-4.18

Financing cash flow

$1.2B

Free cash flow

$-580.7M

Free cash flow minus SBC

$-708M

Gross profit

$-337.4M

Investing cash flow

$-503.7M

Net borrowing

$315M

Net cash flow

$181.8M

Net income

$-894M

Operating cash flow minus SBC

$-682.8M

Operating income

$-707.9M

Revenue

$67.7M

Stock-based compensation

$127.3M

Metric	Value
Altman Z-Score	-1.25
Book value per share	$-1.25
Interest coverage	-5.67
Long-term assets	$716.1M
Long-term liabilities	$1.9B
Net cash (debt)	$-258.8M
Net cash / market cap	-3.08%
Piotroski F-Score	1
Property, plant and equipment	$151.8M
Shareholders' equity	$-173.5M
Tangible book value	$-173.5M
Tangible book value per share	$-1.25
Total assets	$1.9B
Total cash	$1.2B
Total debt	$1.4B
Total liabilities	$2.1B
WACC	6.56%

Metric

Value

Altman Z-Score

-1.25

Book value per share

$-1.25

Interest coverage

-5.67

Long-term assets

$716.1M

Long-term liabilities

$1.9B

Net cash (debt)

$-258.8M

Net cash / market cap

-3.08%

Piotroski F-Score

Property, plant and equipment

$151.8M

Shareholders' equity

$-173.5M

Tangible book value

$-173.5M

Tangible book value per share

$-1.25

Total assets

$1.9B

Total cash

$1.2B

Total debt

$1.4B

Total liabilities

$2.1B

WACC

6.56%

Metric	Value
Asset turnover	0.04
Current assets	$1.2B
Current liabilities	$181.4M
Current ratio	6.66
Net working capital	$-59.5M
Quick ratio	6.56
Working capital	$1B
Working capital turnover	0.08

Metric

Value

Asset turnover

0.04

Current assets

$1.2B

Current liabilities

$181.4M

Current ratio

6.66

Net working capital

$-59.5M

Quick ratio

6.56

Working capital

$1B

Working capital turnover

0.08

Metric	Value
Buyback yield / dilution	-5.07%
Dividend yield	0%
Shareholder yield	-5.07%

Metric

Value

Buyback yield / dilution

-5.07%

Dividend yield

Shareholder yield

-5.07%

Metric	Value
10Y price change	587.83%
10Y return CAGR	21.27%
10Y total return	587.83%
150-day SMA	$72.25
15Y price change	772.63%
15Y return CAGR	15.54%
15Y total return	772.63%
1D price change	-0.34%
1M price change	-6.07%
1M total return	-6.07%
1W price change	-5.03%
1W total return	-5.03%
1Y price change	0.92%
1Y return CAGR	0.92%
1Y total return	0.92%
20-day SMA	$62.55
200-day SMA	$70.08
20Y price change	40.98%
20Y return CAGR	1.73%
20Y total return	40.98%
3M price change	-24.67%
3M total return	-24.67%
3Y price change	91.35%
3Y return CAGR	24.14%
3Y total return	91.35%
50-day SMA	$68.06
50-day SMA vs 200-day SMA	50under200
52-week high	$88.31
52-week high date	2026-06-30
52-week low	$58.05
52-week low date	2025-11-06
5Y price change	73.78%
5Y return CAGR	11.69%
5Y total return	73.78%
6M price change	-1.4%
6M total return	-1.4%
All-time high	$110.25
All-time high date	2024-01-08
All-time low	$3.05
All-time low date	2014-10-13
Average true range (ATR)	$2.01
Average volume	1.7M
Beta (1Y)	0.83
Beta (2Y)	0.87
Beta (5Y)	0.41
Change from 52-week high	-30.57%
Change from 52-week low	5.62%
Change from all-time high	-44.91%
Change from all-time low	1,891.31%
Change from open	0.74%
Day's gap	-1.07%
Dollar volume	$61.6M
High price	$61.31
Low price	$60.19
Monthly RSI	50.65
Open price	$60.86
Position in 52-week range	100%
Premarket change	0.13%
Premarket close	$61.52
Premarket price	$61.60
Premarket volume	29.4K
Previous close	$61.52
Price vs 150-day SMA	-15.94%
Price vs 20-day SMA	-2.9%
Price vs 200-day SMA	-13.34%
Price vs 50-day SMA	-10.77%
Relative volume	0.58
RSI	36.58
Sharpe ratio	0.13
Sharpe ratio (3Y)	0.54
Sharpe ratio (5Y)	0.4
Sortino ratio	0.35
Sortino ratio (3Y)	1.28
Sortino ratio (5Y)	0.84
Volume	1M
Weekly RSI	37.71
YTD price change	-4.41%
YTD total return	-4.41%

Metric

Value

10Y price change

587.83%

10Y return CAGR

21.27%

10Y total return

587.83%

150-day SMA

$72.25

15Y price change

772.63%

15Y return CAGR

15.54%

15Y total return

772.63%

1D price change

-0.34%

1M price change

-6.07%

1M total return

-6.07%

1W price change

-5.03%

1W total return

-5.03%

1Y price change

0.92%

1Y return CAGR

0.92%

1Y total return

0.92%

20-day SMA

$62.55

200-day SMA

$70.08

20Y price change

40.98%

20Y return CAGR

1.73%

20Y total return

40.98%

3M price change

-24.67%

3M total return

-24.67%

3Y price change

91.35%

3Y return CAGR

24.14%

3Y total return

91.35%

50-day SMA

$68.06

50-day SMA vs 200-day SMA

50under200

52-week high

$88.31

52-week high date

2026-06-30

52-week low

$58.05

52-week low date

2025-11-06

5Y price change

73.78%

5Y return CAGR

11.69%

5Y total return

73.78%

6M price change

-1.4%

6M total return

-1.4%

All-time high

$110.25

All-time high date

2024-01-08

All-time low

$3.05

All-time low date

2014-10-13

Average true range (ATR)

$2.01

Average volume

1.7M

Beta (1Y)

0.83

Beta (2Y)

0.87

Beta (5Y)

0.41

Change from 52-week high

-30.57%

Change from 52-week low

5.62%

Change from all-time high

-44.91%

Change from all-time low

1,891.31%

Change from open

0.74%

Day's gap

-1.07%

Dollar volume

$61.6M

High price

$61.31

Low price

$60.19

Monthly RSI

50.65

Open price

$60.86

Position in 52-week range

100%

Premarket change

0.13%

Premarket close

$61.52

Premarket price

$61.60

Premarket volume

29.4K

Previous close

$61.52

Price vs 150-day SMA

-15.94%

Price vs 20-day SMA

-2.9%

Price vs 200-day SMA

-13.34%

Price vs 50-day SMA

-10.77%

Relative volume

0.58

RSI

36.58

Sharpe ratio

0.13

Sharpe ratio (3Y)

0.54

Sharpe ratio (5Y)

0.4

Sortino ratio

0.35

Sortino ratio (3Y)

1.28

Sortino ratio (5Y)

0.84

Volume

Weekly RSI

37.71

YTD price change

-4.41%

YTD total return

-4.41%

Metric	Value
Float	138.5M
Float percentage	99.62%
Shares change (QoQ)	7.15%
Shares change (YoY)	5.07%
Shares held by insiders	0.34%
Shares held by institutions	116.99%
Shares outstanding	139M
Short % of float	13.45%
Short % of shares	13.4%
Short ratio	9.3 days

Metric

Value

Float

138.5M

Float percentage

99.62%

Shares change (QoQ)

7.15%

Shares change (YoY)

5.07%

Shares held by insiders

0.34%

Shares held by institutions

116.99%

Shares outstanding

139M

Short % of float

13.45%

Short % of shares

13.4%

Short ratio

9.3 days

Cytokinetics, Incorporated (CYTK)

Price

Financial snapshot

Fair-value bridge

Latest news · CYTK

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CYTK indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CYTK

Frequently asked questions